Published in Trends Mol Med on May 03, 2010
Four faces of cellular senescence. J Cell Biol (2011) 6.86
Aging, cellular senescence, and cancer. Annu Rev Physiol (2012) 5.08
Neutralizing tumor-promoting chronic inflammation: a magic bullet? Science (2013) 3.91
Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J Clin Invest (2013) 3.47
The extracellular matrix at a glance. J Cell Sci (2010) 3.37
Fat tissue, aging, and cellular senescence. Aging Cell (2010) 3.34
Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity. Genes Dev (2011) 3.05
The role of senescent cells in ageing. Nature (2014) 3.03
HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr (2012) 2.95
An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA. Dev Cell (2014) 2.89
MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation. Nat Cell Biol (2015) 2.85
p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype. EMBO J (2011) 2.61
Cellular senescence: putting the paradoxes in perspective. Curr Opin Genet Dev (2010) 2.49
Pleiotropic actions of estrogen: a mitochondrial matter. Physiol Genomics (2012) 2.07
Lamin B1 loss is a senescence-associated biomarker. Mol Biol Cell (2012) 2.03
Cellular senescence: a link between cancer and age-related degenerative disease? Semin Cancer Biol (2011) 1.98
DNA damaging agents and p53 do not cause senescence in quiescent cells, while consecutive re-activation of mTOR is associated with conversion to senescence. Aging (Albany NY) (2010) 1.97
Mechanisms and metabolic implications of regional differences among fat depots. Cell Metab (2013) 1.94
Cellular senescence in aging and age-related disease: from mechanisms to therapy. Nat Med (2015) 1.82
SIRT1 protects against emphysema via FOXO3-mediated reduction of premature senescence in mice. J Clin Invest (2012) 1.82
Chronic inflammation induces telomere dysfunction and accelerates ageing in mice. Nat Commun (2014) 1.72
Late-life rapamycin treatment reverses age-related heart dysfunction. Aging Cell (2013) 1.60
Cell cycle arrest is not senescence. Aging (Albany NY) (2011) 1.57
Nuclear lamina defects cause ATM-dependent NF-κB activation and link accelerated aging to a systemic inflammatory response. Genes Dev (2012) 1.54
BRD4 Connects Enhancer Remodeling to Senescence Immune Surveillance. Cancer Discov (2016) 1.54
Elevated risk for autoimmune disorders in iraq and afghanistan veterans with posttraumatic stress disorder. Biol Psychiatry (2014) 1.50
AKT induces senescence in human cells via mTORC1 and p53 in the absence of DNA damage: implications for targeting mTOR during malignancy. Oncogene (2011) 1.45
Human RECQ helicases: roles in DNA metabolism, mutagenesis and cancer biology. Semin Cancer Biol (2010) 1.44
MicroRegulators come of age in senescence. Trends Genet (2011) 1.42
Deletion of IGF-1 Receptors in Cardiomyocytes Attenuates Cardiac Aging in Male Mice. Endocrinology (2015) 1.41
Effects of aging on articular cartilage homeostasis. Bone (2012) 1.40
Postmitotic neurons develop a p21-dependent senescence-like phenotype driven by a DNA damage response. Aging Cell (2012) 1.35
IL1- and TGFβ-Nox4 signaling, oxidative stress and DNA damage response are shared features of replicative, oncogene-induced, and drug-induced paracrine 'bystander senescence'. Aging (Albany NY) (2012) 1.32
Age-associated inflammation inhibits epidermal stem cell function. Genes Dev (2012) 1.32
Aging and osteoarthritis. Curr Opin Rheumatol (2011) 1.31
T cell replicative senescence in human aging. Curr Pharm Des (2013) 1.31
Epithelial-mesenchymal transition induced by senescent fibroblasts. Cancer Microenviron (2011) 1.26
Senescent cells: a novel therapeutic target for aging and age-related diseases. Clin Pharmacol Ther (2012) 1.25
p53-dependent release of Alarmin HMGB1 is a central mediator of senescent phenotypes. J Cell Biol (2013) 1.25
Ulcerative colitis-associated colorectal cancer arises in a field of short telomeres, senescence, and inflammation. Cancer Res (2011) 1.23
Exaggerated neurobiological sensitivity to threat as a mechanism linking anxiety with increased risk for diseases of aging. Neurosci Biobehav Rev (2012) 1.22
Senescent cells communicate via intercellular protein transfer. Genes Dev (2015) 1.21
Human mesenchymal stem cell-replicative senescence and oxidative stress are closely linked to aneuploidy. Cell Death Dis (2013) 1.16
Growth hormone action predicts age-related white adipose tissue dysfunction and senescent cell burden in mice. Aging (Albany NY) (2014) 1.15
Aging and reprogramming: a two-way street. Curr Opin Cell Biol (2012) 1.14
Cell senescence: role in aging and age-related diseases. Interdiscip Top Gerontol (2014) 1.14
MiR-146a as marker of senescence-associated pro-inflammatory status in cells involved in vascular remodelling. Age (Dordr) (2012) 1.13
Aging exacerbates obesity-induced oxidative stress and inflammation in perivascular adipose tissue in mice: a paracrine mechanism contributing to vascular redox dysregulation and inflammation. J Gerontol A Biol Sci Med Sci (2012) 1.12
Astrocyte senescence as a component of Alzheimer's disease. PLoS One (2012) 1.11
SIRT1 as a therapeutic target in inflammaging of the pulmonary disease. Prev Med (2011) 1.10
Emerging roles of the p38 MAPK and PI3K/AKT/mTOR pathways in oncogene-induced senescence. Trends Biochem Sci (2014) 1.10
Senescence-associated lncRNAs: senescence-associated long noncoding RNAs. Aging Cell (2013) 1.09
Glucocorticoids suppress selected components of the senescence-associated secretory phenotype. Aging Cell (2012) 1.08
Educational attainment and late life telomere length in the Health, Aging and Body Composition Study. Brain Behav Immun (2012) 1.08
Construction of a computable network model for DNA damage, autophagy, cell death, and senescence. Bioinform Biol Insights (2013) 1.08
Inflammatory priming predisposes mice to age-related retinal degeneration. J Clin Invest (2012) 1.07
Progeria, rapamycin and normal aging: recent breakthrough. Aging (Albany NY) (2011) 1.06
Role of histone deacetylase 2 in epigenetics and cellular senescence: implications in lung inflammaging and COPD. Am J Physiol Lung Cell Mol Physiol (2012) 1.04
Embryonic anti-aging niche. Aging (Albany NY) (2011) 1.02
Aging-related inflammation in osteoarthritis. Osteoarthritis Cartilage (2015) 1.02
Epithelial cell senescence impairs repair process and exacerbates inflammation after airway injury. Respir Res (2011) 1.02
Premature and accelerated aging: HIV or HAART? Front Genet (2013) 1.01
Acute Kidney Injury. Annu Rev Med (2016) 1.01
Oxidative stress and chromatin remodeling in chronic obstructive pulmonary disease and smoking-related diseases. Antioxid Redox Signal (2012) 1.01
Oxidative stress and the ageing endocrine system. Nat Rev Endocrinol (2013) 1.00
Mitochondrial DNA damage induces apoptosis in senescent cells. Cell Death Dis (2013) 1.00
Caveolin-1 deficiency protects from pulmonary fibrosis by modulating epithelial cell senescence in mice. Am J Respir Cell Mol Biol (2012) 1.00
The Menin-Bach2 axis is critical for regulating CD4 T-cell senescence and cytokine homeostasis. Nat Commun (2014) 1.00
Toll like receptor signaling in "inflammaging": microRNA as new players. Immun Ageing (2013) 0.99
Radiation-induced senescence in securin-deficient cancer cells promotes cell invasion involving the IL-6/STAT3 and PDGF-BB/PDGFR pathways. Sci Rep (2013) 0.99
Increased cellular senescence and vascular rarefaction exacerbate the progression of kidney fibrosis in aged mice following transient ischemic injury. PLoS One (2013) 0.99
The role of oxidative stress and inflammation in cardiovascular aging. Biomed Res Int (2014) 0.98
p53: Pro-aging or pro-longevity? Aging (Albany NY) (2010) 0.98
Cellular Senescence - its role in cancer and the response to ionizing radiation. Genome Integr (2011) 0.98
miRNAs: roles and clinical applications in vascular disease. Expert Rev Mol Diagn (2011) 0.98
Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity. Diabetes (2015) 0.98
Clinical strategies and animal models for developing senolytic agents. Exp Gerontol (2014) 0.96
Interplay between DNA repair and inflammation, and the link to cancer. Crit Rev Biochem Mol Biol (2014) 0.96
Epidemiology and long-term clinical and biologic risk factors for pneumonia in community-dwelling older Americans: analysis of three cohorts. Chest (2013) 0.96
Senescence in chronic obstructive pulmonary disease. Proc Am Thorac Soc (2012) 0.95
Altered MCM protein levels and autophagic flux in aged and systemic sclerosis dermal fibroblasts. J Invest Dermatol (2014) 0.95
Bisphosphonates induce senescence in normal human oral keratinocytes. J Dent Res (2011) 0.95
Signalling of DNA damage and cytokines across cell barriers exposed to nanoparticles depends on barrier thickness. Nat Nanotechnol (2011) 0.94
Prolonged neuroinflammation after lipopolysaccharide exposure in aged rats. PLoS One (2014) 0.94
Thymic involution perturbs negative selection leading to autoreactive T cells that induce chronic inflammation. J Immunol (2015) 0.93
Immune aging, dysmetabolism, and inflammation in neurological diseases. Front Neurosci (2015) 0.92
Long noncoding RNAs(lncRNAs) and the molecular hallmarks of aging. Aging (Albany NY) (2014) 0.92
Incorporating biomarkers into cancer and aging research. J Clin Oncol (2014) 0.92
Altered cytokine profiles of human retinal pigment epithelium: oxidant injury and replicative senescence. Mol Vis (2013) 0.91
Inflammaging and cancer: a challenge for the Mediterranean diet. Nutrients (2015) 0.91
Epigenetic clock analyses of cellular senescence and ageing. Oncotarget (2016) 0.90
Pleiotropic cellular functions of PARP1 in longevity and aging: genome maintenance meets inflammation. Oxid Med Cell Longev (2012) 0.90
Brd2 gene disruption causes "metabolically healthy" obesity: epigenetic and chromatin-based mechanisms that uncouple obesity from type 2 diabetes. Vitam Horm (2013) 0.90
Forum on aging and skeletal health: summary of the proceedings of an ASBMR workshop. J Bone Miner Res (2011) 0.90
Linking JNK Activity to the DNA Damage Response. Genes Cancer (2013) 0.89
Molecular processes that drive cigarette smoke-induced epithelial cell fate of the lung. Am J Respir Cell Mol Biol (2014) 0.89
Sleep and immune function: glial contributions and consequences of aging. Curr Opin Neurobiol (2013) 0.89
Senescent cardiac fibroblast is critical for cardiac fibrosis after myocardial infarction. PLoS One (2013) 0.89
Ageing and the pathogenesis of osteoarthritis. Nat Rev Rheumatol (2016) 0.89
Systemic DNA damage related to cancer. Cancer Res (2011) 0.88
A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A (1995) 32.89
NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A (2006) 21.58
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature (2007) 16.95
BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature (2005) 16.87
Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol (2007) 16.55
Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell (2005) 12.73
Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol (2008) 11.43
Points of control in inflammation. Nature (2002) 10.61
An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell (2009) 10.09
Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell (2008) 9.22
Oncogene-induced senescence as an initial barrier in lymphoma development. Nature (2005) 9.16
Senescence of activated stellate cells limits liver fibrosis. Cell (2008) 8.98
Ink4a/Arf expression is a biomarker of aging. J Clin Invest (2004) 8.30
Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci (2000) 8.26
Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc Natl Acad Sci U S A (2001) 7.93
Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat Cell Biol (2009) 7.74
Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell (2008) 7.65
The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol (2010) 7.58
Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell (2008) 6.84
Senescence in tumours: evidence from mice and humans. Nat Rev Cancer (2010) 6.34
Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome. Nat Genet (2004) 5.64
Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev (2006) 5.61
DNA repair, genome stability, and aging. Cell (2005) 5.52
Senescence-messaging secretome: SMS-ing cellular stress. Nat Rev Cancer (2009) 5.02
The signals and pathways activating cellular senescence. Int J Biochem Cell Biol (2004) 5.00
p38 MAP-kinases pathway regulation, function and role in human diseases. Biochim Biophys Acta (2007) 4.80
Living on a break: cellular senescence as a DNA-damage response. Nat Rev Cancer (2008) 4.63
NF-kappaB and cancer-identifying targets and mechanisms. Curr Opin Genet Dev (2008) 4.61
Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation. J Cell Sci (2005) 3.96
Accumulation of senescent cells in mitotic tissue of aging primates. Mech Ageing Dev (2006) 3.14
The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms. Cancer Res (2006) 3.07
Secretion of vascular endothelial growth factor by primary human fibroblasts at senescence. J Biol Chem (2006) 3.00
Senescent human fibroblasts increase the early growth of xenograft tumors via matrix metalloproteinase secretion. Cancer Res (2007) 2.94
Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop. Mol Cell Biol (1993) 2.90
The power and the promise of oncogene-induced senescence markers. Nat Rev Cancer (2006) 2.85
Interleukin-6 in aging and chronic disease: a magnificent pathway. J Gerontol A Biol Sci Med Sci (2006) 2.85
Inflammatory networks in ageing, age-related diseases and longevity. Mech Ageing Dev (2006) 2.82
Cell surface-bound IL-1alpha is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network. Proc Natl Acad Sci U S A (2009) 2.82
Sequential activation of the MEK-extracellular signal-regulated kinase and MKK3/6-p38 mitogen-activated protein kinase pathways mediates oncogenic ras-induced premature senescence. Mol Cell Biol (2002) 2.70
The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis. Proc Natl Acad Sci U S A (2006) 2.64
MicroRNAs miR-146a/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8. Aging (Albany NY) (2009) 2.49
A human-like senescence-associated secretory phenotype is conserved in mouse cells dependent on physiological oxygen. PLoS One (2010) 2.38
Mitogen-activated protein kinase p38 defines the common senescence-signalling pathway. Genes Cells (2003) 2.28
Immunosenescence: what does it mean to health outcomes in older adults? Curr Opin Immunol (2009) 2.09
The role of chondrocyte senescence in osteoarthritis. Aging Cell (2002) 2.06
Oncogene-induced senescence: putting the brakes on tumor development. Cancer Res (2006) 2.04
Senescence in human intervertebral discs. Eur Spine J (2006) 2.00
Aging, longevity, inflammation, and cancer. Ann N Y Acad Sci (2004) 1.96
Cellular senescence in vivo: its relevance in ageing and cardiovascular disease. Exp Gerontol (2005) 1.96
Remodeling of chromatin structure in senescent cells and its potential impact on tumor suppression and aging. Gene (2007) 1.92
Stem cell review series: aging of the skeletal muscle stem cell niche. Aging Cell (2008) 1.90
Loss of stem cell regenerative capacity within aged niches. Aging Cell (2007) 1.83
Molecular mechanisms of aging-associated inflammation. Cancer Lett (2005) 1.80
IGF-1, inflammation and stem cells: interactions during muscle regeneration. Trends Immunol (2005) 1.79
Fibroblasts isolated from common sites of breast cancer metastasis enhance cancer cell growth rates and invasiveness in an interleukin-6-dependent manner. Cancer Res (2008) 1.78
Aging of the immune system: a risk factor for autoimmunity? Autoimmun Rev (2005) 1.65
Cellular senescence in the pathogenesis of benign prostatic hyperplasia. Prostate (2003) 1.61
IL-17 stimulates the proliferation and differentiation of human mesenchymal stem cells: implications for bone remodeling. Cell Death Differ (2009) 1.53
Expression of senescence-associated beta-galactosidase in enlarged prostates from men with benign prostatic hyperplasia. Urology (2000) 1.45
Identification of an autoregulatory feedback pathway involving interleukin-1alpha in induction of constitutive NF-kappaB activation in pancreatic cancer cells. J Biol Chem (2003) 1.42
Expression of interleukin 1-inducible genes and production of interleukin 1 by aging human fibroblasts. Proc Natl Acad Sci U S A (1992) 1.34
Dissection of a DNA-damage-induced transcriptional network using a combination of microarrays, RNA interference and computational promoter analysis. Genome Biol (2005) 1.31
SASP reflects senescence. EMBO Rep (2009) 1.27
Cellular senescence and chromatin structure. Chromosoma (2007) 1.26
A flame burning within. Aging Clin Exp Res (2004) 1.26
p38alpha and p38gamma mediate oncogenic ras-induced senescence through differential mechanisms. J Biol Chem (2009) 1.19
Alterations to nuclear architecture and genome behavior in senescent cells. Ann N Y Acad Sci (2007) 1.11
Altered expression of plasminogen activator and plasminogen activator inhibitor during cellular senescence. Exp Gerontol (1996) 1.09
Remodeling chromatin for senescence. Aging Cell (2007) 1.06
Cellular senescence and chromatin organisation. Br J Cancer (2007) 1.06
Cytokine expression in chronic inflammatory disease. Br Med Bull (1995) 1.06
Interleukin-27 directly induces differentiation in hematopoietic stem cells. Blood (2007) 1.05
Unregulated inflammation shortens human functional longevity. Inflamm Res (2000) 1.05
The clinical impact of systemic low-level inflammation in elderly populations. With special reference to cardiovascular disease, dementia and mortality. Dan Med Bull (2006) 1.04
Characterization of IGFBP-3, PAI-1 and SPARC mRNA expression in senescent fibroblasts. Mech Ageing Dev (1996) 1.00
Glioma-associated endothelial cells show evidence of replicative senescence. Exp Cell Res (2007) 0.91
Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol (2008) 11.43
Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts. Nat Cell Biol (2003) 8.42
Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat Cell Biol (2009) 7.74
The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol (2010) 7.58
Four faces of cellular senescence. J Cell Biol (2011) 6.86
Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J (2003) 5.61
Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. Nat Protoc (2009) 4.47
Control of the replicative life span of human fibroblasts by p16 and the polycomb protein Bmi-1. Mol Cell Biol (2003) 4.05
Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation. J Cell Sci (2005) 3.96
A versatile viral system for expression and depletion of proteins in mammalian cells. PLoS One (2009) 3.83
Aging and genome maintenance: lessons from the mouse? Science (2003) 3.72
Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J Clin Invest (2013) 3.47
Puzzles, promises and a cure for ageing. Nature (2008) 3.23
Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B. Nat Med (2012) 3.21
The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells. Cancer Res (2002) 3.16
Removal of a single pore subcomplex results in vertebrate nuclei devoid of nuclear pores. Mol Cell (2003) 3.01
Secretion of vascular endothelial growth factor by primary human fibroblasts at senescence. J Biol Chem (2006) 3.00
Cell surface-bound IL-1alpha is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network. Proc Natl Acad Sci U S A (2009) 2.82
Two faces of p53: aging and tumor suppression. Nucleic Acids Res (2007) 2.78
p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype. EMBO J (2011) 2.61
TIN2 mediates functions of TRF2 at human telomeres. J Biol Chem (2004) 2.52
MicroRNAs miR-146a/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8. Aging (Albany NY) (2009) 2.49
Methods to detect biomarkers of cellular senescence: the senescence-associated beta-galactosidase assay. Methods Mol Biol (2007) 2.42
A human-like senescence-associated secretory phenotype is conserved in mouse cells dependent on physiological oxygen. PLoS One (2010) 2.38
DNA-SCARS: distinct nuclear structures that sustain damage-induced senescence growth arrest and inflammatory cytokine secretion. J Cell Sci (2010) 2.34
Senescent cells as a source of inflammatory factors for tumor progression. Cancer Metastasis Rev (2010) 2.32
Zinc-finger protein-targeted gene regulation: genomewide single-gene specificity. Proc Natl Acad Sci U S A (2003) 2.24
The DNA repair endonuclease XPG interacts directly and functionally with the WRN helicase defective in Werner syndrome. Cell Cycle (2011) 2.15
ELYS is a dual nucleoporin/kinetochore protein required for nuclear pore assembly and proper cell division. Proc Natl Acad Sci U S A (2006) 2.14
Tumor suppressor and aging biomarker p16(INK4a) induces cellular senescence without the associated inflammatory secretory phenotype. J Biol Chem (2011) 2.11
Cancer and aging: a model for the cancer promoting effects of the aging stroma. Int J Biochem Cell Biol (2002) 2.08
Lamin B1 loss is a senescence-associated biomarker. Mol Biol Cell (2012) 2.03
Ageing: balancing regeneration and cancer. Nature (2006) 1.88
Mechanisms of cellular senescence in human and mouse cells. Biogerontology (2004) 1.76
Telomeres, aging and cancer: in search of a happy ending. Oncogene (2002) 1.69
Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis. Proc Natl Acad Sci U S A (2003) 1.68
Cancer and aging: the importance of telomeres in genome maintenance. Int J Biochem Cell Biol (2005) 1.64
Scaffold function of long non-coding RNA HOTAIR in protein ubiquitination. Nat Commun (2013) 1.62
A novel form of the telomere-associated protein TIN2 localizes to the nuclear matrix. Cell Cycle (2009) 1.58
Mitochondrial oxidative stress caused by Sod2 deficiency promotes cellular senescence and aging phenotypes in the skin. Aging (Albany NY) (2012) 1.57
Oxygen accelerates the accumulation of mutations during the senescence and immortalization of murine cells in culture. Aging Cell (2003) 1.55
Reversible manipulation of telomerase expression and telomere length. Implications for the ionizing radiation response and replicative senescence of human cells. J Biol Chem (2002) 1.50
Oncogene-induced senescence pathways weave an intricate tapestry. Cell (2007) 1.47
Ionizing radiation-induced long-term expression of senescence markers in mice is independent of p53 and immune status. Aging Cell (2010) 1.43
Time to talk SENS: critiquing the immutability of human aging. Ann N Y Acad Sci (2002) 1.42
Transforming growth factor-beta can suppress tumorigenesis through effects on the putative cancer stem or early progenitor cell and committed progeny in a breast cancer xenograft model. Cancer Res (2007) 1.42
Id-1 and Id-2 proteins as molecular markers for human prostate cancer progression. Clin Cancer Res (2004) 1.33
Id genes and proteins as promising targets in cancer therapy. Trends Mol Med (2004) 1.33
Bloom syndrome cells undergo p53-dependent apoptosis and delayed assembly of BRCA1 and NBS1 repair complexes at stalled replication forks. J Cell Biol (2003) 1.32
A role for p53 in maintaining and establishing the quiescence growth arrest in human cells. J Biol Chem (2002) 1.27
Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells. Mol Cancer Ther (2007) 1.27
Epithelial-mesenchymal transition induced by senescent fibroblasts. Cancer Microenviron (2011) 1.26
Targeted quantitation of site-specific cysteine oxidation in endogenous proteins using a differential alkylation and multiple reaction monitoring mass spectrometry approach. Mol Cell Proteomics (2010) 1.26
Collaboration of Werner syndrome protein and BRCA1 in cellular responses to DNA interstrand cross-links. Nucleic Acids Res (2006) 1.26
p53-dependent release of Alarmin HMGB1 is a central mediator of senescent phenotypes. J Cell Biol (2013) 1.25
Telomere length mediates the effects of telomerase on the cellular response to genotoxic stress. Exp Cell Res (2004) 1.24
WRN, the protein deficient in Werner syndrome, plays a critical structural role in optimizing DNA repair. Aging Cell (2003) 1.23
SKI activates Wnt/beta-catenin signaling in human melanoma. Cancer Res (2003) 1.22
The thorny path linking cellular senescence to organismal aging. Mech Ageing Dev (2005) 1.22
Correction of cellular phenotypes of Hutchinson-Gilford Progeria cells by RNA interference. Hum Genet (2005) 1.22
The role of inflammation in age-related disease. Aging (Albany NY) (2013) 1.22
Quantification of epithelial cells in coculture with fibroblasts by fluorescence image analysis. Cytometry (2002) 1.21
Role of Id-2 in the maintenance of a differentiated and noninvasive phenotype in breast cancer cells. Cancer Res (2003) 1.21
p53-dependent integration of telomere and growth factor deprivation signals. Proc Natl Acad Sci U S A (2007) 1.18
E6/E7 of HPV type 16 promotes cell invasion and metastasis of human breast cancer cells. Cell Cycle (2007) 1.18
Lack of WRN results in extensive deletion at nonhomologous joining ends. Cancer Res (2002) 1.18
Higher-order nuclear organization in growth arrest of human mammary epithelial cells: a novel role for telomere-associated protein TIN2. J Cell Sci (2005) 1.17
ATR and ATM-dependent movement of BLM helicase during replication stress ensures optimal ATM activation and 53BP1 focus formation. Cell Cycle (2004) 1.15
Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis. Breast Cancer Res Treat (2010) 1.14
Id-1 is a key transcriptional regulator of glioblastoma aggressiveness and a novel therapeutic target. Cancer Res (2012) 1.14
Telomere dysfunction and cell survival: roles for distinct TIN2-containing complexes. J Cell Biol (2008) 1.14
Generation and characterization of telomere length maintenance in tankyrase 2-deficient mice. Mol Cell Biol (2006) 1.13
Depletion of cellular polyamines, spermidine and spermine, causes a total arrest in translation and growth in mammalian cells. Proc Natl Acad Sci U S A (2013) 1.13
Glucocorticoids suppress selected components of the senescence-associated secretory phenotype. Aging Cell (2012) 1.08
Telomere-associated protein TIN2 is essential for early embryonic development through a telomerase-independent pathway. Mol Cell Biol (2004) 1.08
The demographic and biomedical case for late-life interventions in aging. Sci Transl Med (2010) 1.08
Vascular endothelial platelet endothelial cell adhesion molecule 1 (PECAM-1) regulates advanced metastatic progression. Proc Natl Acad Sci U S A (2010) 1.07
Replication timing of human telomeres is chromosome arm-specific, influenced by subtelomeric structures and connected to nuclear localization. PLoS Genet (2010) 1.06
Between Scylla and Charybdis: p53 links tumor suppression and aging. Mech Ageing Dev (2002) 1.05
The human telomere-associated protein TIN2 stimulates interactions between telomeric DNA tracts in vitro. EMBO Rep (2003) 1.03
Profiling of gene expression changes caused by p53 gain-of-function mutant alleles in prostate cancer cells. Prostate (2005) 1.02
Id proteins in epithelial cells. Exp Cell Res (2003) 1.01
Cell senescence abrogates the therapeutic potential of human mesenchymal stem cells in the lethal endotoxemia model. Stem Cells (2014) 1.01
Aging: past, present and future. Aging (Albany NY) (2009) 1.01
Senescent cells and their secretory phenotype as targets for cancer therapy. Interdiscip Top Gerontol (2013) 1.00
Cannabidiol enhances the inhibitory effects of delta9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival. Mol Cancer Ther (2010) 1.00
Comprehensive microRNA profiling in B-cells of human centenarians by massively parallel sequencing. BMC Genomics (2012) 0.99
mTORC1 and p53: clash of the gods? Cell Cycle (2013) 0.98
Mutant frequencies and spectra depend on growth state and passage number in cells cultured from transgenic lacZ-plasmid reporter mice. DNA Repair (Amst) (2005) 0.98
Identification of gene function and functional pathways by systemic plasmid-based ribozyme targeting in adult mice. Proc Natl Acad Sci U S A (2002) 0.98